By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
News for IndiaNews for IndiaNews for India
  • Home
  • Posts
  • Search Page
  • About us
Reading: Pine Labs shares rose over 2% after Q2 results. Should you buy, sell or hold? | Stock Market News
Share
Font ResizerAa
News for IndiaNews for India
Font ResizerAa
  • Economics
  • Business
  • Home
  • Categories
    • Business
    • Economics
  • About us
  • Sitemap
Follow US
  • Advertise
© 2022 Foxiz News Network. Ruby Design Company. All Rights Reserved.
News for India > Business > Pine Labs shares rose over 2% after Q2 results. Should you buy, sell or hold? | Stock Market News
Business

Pine Labs shares rose over 2% after Q2 results. Should you buy, sell or hold? | Stock Market News

Last updated: December 4, 2025 11:10 am
2 months ago
Share
SHARE


Pine Labs shares rose 2.5% during Thursday’s trading session after the payment solutions firm reported a consolidated net profit of ₹6 crore for the quarter ending September, marking a return to profitability following a loss of ₹32 crore in the same period last year.

In the second quarter of FY26, the company achieved revenue from operations amounting to ₹650 crore, which represents an 18% increase from ₹552 crore in the equivalent quarter of the previous financial year.

The profit after tax (PAT) increased by 25% compared to the previous quarter, which saw ₹5 crore in Q1FY26, while the topline also saw a nearly 6% rise quarter-on-quarter, compared to ₹616 crore in the April-June period of FY26.

The adjusted Earnings Before Interest, Taxes, Depreciation, and Amortisation (EBITDA) surged 62% year-on-year to reach ₹122 crore, with margins improving from 14% to 19%, demonstrating significant operating leverage.

Also Read | IndiGo share price cracks 2% amid flight cancellation row. Do you own?

A significant decrease in ESOP expenses offered some relief. ESOP costs decreased to ₹29 crore from ₹66 crore in the prior quarter, indicating a 28% drop compared to the same period last year. The proportion of ESOP expenses relative to revenue fell to 4% from 7% both a year earlier and in the previous quarter.

This announcement marks Pine Labs’ first set of earnings since it made its market debut in November of this year.

According to a report by Emkay Global Financial Services, Pine Labs experienced a revenue growth of 17.8% year-over-year, with significant increases in the Issuing and Acquiring sectors (up 32.5% YoY) offsetting the slower growth in the Digital Infrastructure and Transaction Processing (DITP) sector (up 11.9% YoY). EBITDA saw a rise of 46.7% quarter-over-quarter and 132% year-over-year due to operational efficiencies.

Further, Emkay Global highlighted that the management pointed out that Issuing, VAS, Affordability, and Online segments are all growing at rates exceeding 30% year-over-year. Nonetheless, revenue growth in the DITP segment was hindered by the company’s shift from hardware-inclusive agreements to software-focused contracts. The scaling up of the Affordability segment has led to increased working capital investments, resulting in a free cash flow of ₹(2.15) billion for the first half of FY26.

Also Read | K K Silk Mills makes a weak debut, stock opens with a 15.79% discount on BSE SME

“We are increasing our FY26E/27E EBITDA by 4.5%/5.2% on account of strong growth in the Issuing and Acquiring business. On FY28E, the stock trades at 27x EV/EBITDA and 52.9x P/E. We increase our DCF-based TP to ₹225 ( ₹210 earlier). However, we maintain REDUCE, given rising competitive intensity,” said the brokerage.

Pine Labs shares today

Pine Labs shares today opened at ₹250 apiece on the BSE, the stock touched an intraday high of ₹253.90 per share, and an intraday low of ₹245.20 per share. The stock was listed at a 13.52% premium at ₹251 over the issue price. The stock is currently trading at ₹253.90, up 14.88 over the issue price of ₹221.

Following the listing, there has been a significant sell-off, and the stock has experienced volatile sessions.

Also Read | SPARC share price jumps another 11%, rallies 34% in two sessions

Disclaimer: The views and recommendations above are those of individual analysts, experts and broking companies, not of Mint. We advise investors to check with certified experts before making any investment decision.



Source link

You Might Also Like

Access Denied

Access Denied

Access Denied

Access Denied

Access Denied

TAGGED:consolidated net profitEBITDAPine Labspine labs sharesq2 resultsrevenue from operationsstock trading.
Share This Article
Facebook Twitter Email Print
Previous Article IT gains push Indian benchmark shares higher; rupee hits all-time low | Stock Market News
Next Article Astron Multigrain IPO allotment in focus: GMP, steps to check share allotment status online for SME IPO | Stock Market News

We influence 20 million users and is the number one business and technology news network on the planet.

Find Us on Socials

News for IndiaNews for India
© Wealth Wave Designed by Preet Patel. All Rights Reserved.
  • BUSINESS